Virus Filtration Market 2030: Analyzing the Demand for HEPA Filters in Asia Pacific

The global virus filtration market was valued at approximately USD 4.26 billion in 2022 and is projected to expand at a compound annual growth rate (CAGR) of 10.1% from 2023 to 2030. This growth is largely driven by the increasing incidence of chronic diseases such as cancer, diabetes, and autoimmune disorders, which are expected to boost the demand for biologics and related therapies. According to the World Health Organization (WHO), approximately 422 million people worldwide are currently affected by diabetes. The prevalence of diabetes is notably higher in low- and middle-income countries compared to high-income nations. Diabetes is associated with several severe complications, including lower limb amputations, kidney disease, cardiac arrest, stroke, and blindness. Between 2000 and 2019, mortality rates from diabetes rose by 3% across all age groups, and in 2019 alone, an estimated 2 million people died from diabetes-related kidney disease, according to the WHO.

Additionally, the COVID-19 pandemic had a significant, positive effect on the virus filtration market. The pandemic underscored the critical need for effective sterilization of biopharmaceutical products, vaccines, medical devices, and air and water systems to protect against viral contamination. Virus filtration plays an essential role in ensuring the safety, purity, and effectiveness of these products, and it is also vital for preventing the spread of infectious diseases. As the pandemic has highlighted the importance of viral filtration in the healthcare and pharmaceutical industries, the market for virus filtration is expected to continue to experience strong growth in the coming years.

Gather more insights about the market drivers, restrains and growth of the Virus Filtration Market

Regional Insights

North America was the leading region in the global virus filtration market, capturing the largest revenue share of 41.2% in 2022. This dominance can be attributed to the well-established biotechnology and biopharmaceutical sectors in the United States, which have significantly contributed to the increased demand for advanced viral clearance solutions. These solutions are essential for both research and development (R&D) and the manufacturing of biologics, where maintaining high standards of safety and purity is critical. As a result, North America is expected to continue to play a central role in driving the growth of the virus filtration market, particularly in the fields of biotechnology, pharmaceuticals, and healthcare.

Asia Pacific, on the other hand, is anticipated to experience the fastest growth in the market, with a projected compound annual growth rate (CAGR) of 12.0% from 2023 to 2030. This rapid growth is primarily driven by several factors, including the increasing number of road accidents and trauma cases in the region, which create a demand for better medical devices and biologics that require virus filtration. In addition, the region is witnessing untapped growth opportunities, especially in fast-developing economies like China, India, and Indonesia, which are expected to fuel market expansion. These countries are increasingly attractive to global manufacturers due to government support for industrialization, the growth of contract research organizations (CROs), and the availability of low-cost labor, all of which contribute to the region’s appeal for setting up production and R&D facilities.

Furthermore, the regulatory environment in many parts of Asia Pacific is relatively less stringent compared to Western countries, making it easier for companies to enter and expand in these markets. The combination of these factors is expected to drive significant growth in the demand for virus filtration products across the region.

In terms of traffic-related injuries, some countries in Southeast Asia have high mortality rates, which is contributing to the rising demand for medical interventions. According to the World Health Organization (WHO) statistics from 2019, Thailand and Vietnam had some of the highest traffic fatality rates in the region, with rates of 32.2 and 30.5 deaths per 100,000 people, respectively. Other countries like Malaysia (22.4), Myanmar (20.3), Cambodia (19.5), and Laos (17.8) also showed concerning traffic death rates. In stark contrast, Singapore recorded a much lower traffic fatality rate, with only 2 deaths per 100,000 people. These statistics highlight the public health challenges in the region, further increasing the need for advanced healthcare solutions, including biologics and medical devices that require rigorous virus filtration.

Browse through Grand View Research's Category Biotechnology Industry Research Reports.

The global cell culture media market size was estimated at USD 4.73 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 12.54% from 2024 to 2030.
The global downstream processing market size was estimated at USD 30.96 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 14.84% from 2023 to 2030.

Key Companies & Market Share Insights

The rise in competition is leading to rapid technological advancements and companies are constantly working towards the improvement of their products with a major focus on research and development. The market players are indulging themselves in the constant development of new and better virus filtration. Major manufacturers provide advanced products through strong distribution channels across the globe. For instance, Sartorius has a presence in more than 110 countries with around 30 sales offices and 20 manufacturing sites worldwide. Leading manufacturers are involved in mergers and acquisitions, strategic collaborations, and novel product development to gain revenue share in the industry.

Some prominent players in the global virus filtration market include: